Search Results for ''

published presentations and documents on DocSlides.

The Evidence  –  PrEP  Effectiveness
The Evidence – PrEP Effectiveness
by lindy-dunigan
Module . 1(b). The Evidence in Detail. Session Ov...
Michael S.  Saag , MD  Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by cheryl-pisano
FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA ....
NRTI-sparing
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Tenofovir
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
Phase 2 of new ARVs
Phase 2 of new ARVs
by mitsue-stanley
Fostemsavir. , . prodrug. of . temsavir. . (. a...
Schéma
Schéma
by tatiana-dople
de . l’étude. Critère. principal . –. pu...
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
937401234123534671341849346744x 19 333133Webinar Requirements  A c
937401234123534671341849346744x 19 333133Webinar Requirements A c
by erica
HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...
Treating HIV Infection: HIV/AIDS Treatment
Treating HIV Infection: HIV/AIDS Treatment
by celsa-spraggs
A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...
Use the Web Browser on Your Mobile Device to Participate in Polling*
Use the Web Browser on Your Mobile Device to Participate in Polling*
by phoebe-click
Go to: pollev.com/CCO2. or scan the QR code below...
1 Fundación Huésped, Buenos Aires, Argentina;
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
P1084s: Impact  of maternal
P1084s: Impact of maternal
by olivia-moreira
tenofovir. . disoproxil. . fumarate. (TDF) . u...
Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by tatyana-admore
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
The Evidence
The Evidence
by danika-pritchard
– . PrEP. Effectiveness. Module . 1(b). The Ev...
Overview of HIV Epidemiology and Prevention Sciences for ke
Overview of HIV Epidemiology and Prevention Sciences for ke
by alida-meadow
Stefan Baral, MD MPH FRCPC. Center for Public Hea...
State
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
When and What To Start Melanie A. Thompson, MD
When and What To Start Melanie A. Thompson, MD
by paxton651
Thacker & Thompson, MD. Atlanta, Georgia. Fina...
Introduction Characteristics, Treatment Patterns,
Introduction Characteristics, Treatment Patterns,
by cappi
and . Virologic. Outcomes . for Treatment-experie...
IAS – USA Fall New York Course: Case Discussion
IAS – USA Fall New York Course: Case Discussion
by jalin
Luke . Jerram. Disclosures: Educational grant supp...
Generic  tenofovir   disoproxil
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
Interactive ART Cases From the Clinic: Is There One Right Answer?
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Comparison of INSTI  vs  EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
PrEP to Prevent HIV and Promote Sexual Health
PrEP to Prevent HIV and Promote Sexual Health
by cheryl-pisano
PrEP to Prevent HIV and Promote Sexual Health www...
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
by alida-meadow
Treating and Preventing HIV in 2019: Interactive ...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by natalia-silvester
Program. Improving Health. . . Promoting Wellness...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by yoshiko-marsland
Program. Improving Health. . . Promoting Wellness...
Comprehensive  Guideline Summary
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...
Les satisfactions : traitements efficaces, robustes, avec u
Les satisfactions : traitements efficaces, robustes, avec u
by phoebe-click
Dr Denis Lacoste. Bordeaux. Les satisfactions : ....
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
PROUD: Results and participant experiences
PROUD: Results and participant experiences
by catherine
Presented by . Mitzy. . Gafos. , behalf of the P...
PrEP  scale up and STI management in Brazil
PrEP scale up and STI management in Brazil
by winnie
Valdilea. G. . Veloso. @. Valdilea. Share your th...
Susan P. Buchbinder, MD Director, Bridge HIV
Susan P. Buchbinder, MD Director, Bridge HIV
by harmony
San . Francisco Department . of Public Health. Cli...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...